| Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen G Denkberg, A Lev, L Eisenbach, I Benhar, Y Reiter The Journal of Immunology 171 (5), 2197-2207, 2003 | 783 | 2003 |
| Biotechnological applications of phage and cell display I Benhar Biotechnology advances 19 (1), 1-33, 2001 | 383 | 2001 |
| A modular platform for targeted RNAi therapeutics R Kedmi, N Veiga, S Ramishetti, M Goldsmith, D Rosenblum, N Dammes, ... Nature nanotechnology 13 (3), 214-219, 2018 | 348 | 2018 |
| Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies H Bach, Y Mazor, S Shaky, A Shoham-Lev, Y Berdichevsky, DL Gutnick, ... Journal of molecular biology 312 (1), 79-93, 2001 | 257 | 2001 |
| Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity L Bachmetov, M Gal‐Tanamy, A Shapira, M Vorobeychik, ... Journal of viral hepatitis 19 (2), e81-e88, 2012 | 252 | 2012 |
| Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders L Brimberg, I Benhar, A Mascaro-Blanco, K Alvarez, D Lotan, C Winter, ... Neuropsychopharmacology 37 (9), 2076-2087, 2012 | 244 | 2012 |
| Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima S Ben-Horin, M Yavzori, I Benhar, E Fudim, O Picard, B Ungar, SY Lee, ... Gut 65 (7), 1132-1138, 2016 | 234 | 2016 |
| Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide Y Mazor, S Gilead, I Benhar, E Gazit Journal of Molecular Biology 322 (5), 1013-1024, 2002 | 234 | 2002 |
| Killing cancer cells by targeted drug-carrying phage nanomedicines H Bar, I Yacoby, I Benhar BMC biotechnology 8 (1), 37, 2008 | 224 | 2008 |
| Targeting antibacterial agents by using drug-carrying filamentous bacteriophages I Yacoby, M Shamis, H Bar, D Shabat, I Benhar Antimicrobial agents and chemotherapy 50 (6), 2087-2097, 2006 | 210 | 2006 |
| Insights into the bovine rumen plasmidome AB Kav, G Sasson, E Jami, A Doron-Faigenboim, I Benhar, I Mizrahi Proceedings of the National Academy of Sciences 109 (14), 5452-5457, 2012 | 197 | 2012 |
| Toxin-based therapeutic approaches A Shapira, I Benhar Toxins 2 (11), 2519-2583, 2010 | 195 | 2010 |
| Targeted drug-carrying bacteriophages as antibacterial nanomedicines I Yacoby, H Bar, I Benhar Antimicrobial agents and chemotherapy 51 (6), 2156-2163, 2007 | 192 | 2007 |
| Antibody-targeted drugs and drug resistance—challenges and solutions LR Shefet-Carasso, I Benhar Drug Resistance Updates 18, 36-46, 2015 | 183 | 2015 |
| Synthetic cells synthesize therapeutic proteins inside tumors N Krinsky, M Kaduri, A Zinger, J Shainsky‐Roitman, M Goldfeder, ... Advanced healthcare materials 7 (9), 1701163, 2018 | 174 | 2018 |
| Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes R Mazor, JA Eberle, X Hu, AN Vassall, M Onda, R Beers, EC Lee, ... Proceedings of the National Academy of Sciences 111 (23), 8571-8576, 2014 | 141 | 2014 |
| Modulation of Alzheimer’s β-amyloid neurotoxicity by site-directed single-chain antibody D Frenkel, B Solomon, I Benhar Journal of neuroimmunology 106 (1-2), 23-31, 2000 | 136 | 2000 |
| Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A R Mazor, AN Vassall, JA Eberle, R Beers, JE Weldon, DJ Venzon, ... Proceedings of the National Academy of Sciences 109 (51), E3597-E3603, 2012 | 134 | 2012 |
| Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for … M Li, F Dyda, I Benhar, I Pastan, DR Davies Proceedings of the National Academy of Sciences 93 (14), 6902-6906, 1996 | 129 | 1996 |
| Immune checkpoint inhibitor combinations: Current efforts and important aspects for success E Kon, I Benhar Drug Resistance Updates 45, 13-29, 2019 | 124 | 2019 |
Ran Tur-KaspaDean of medicine, Faculty of medicine, Bar-Ilan university,IsraelVerified email at biu.ac.il
